Sophia Stock

993 total citations
16 papers, 383 citations indexed

About

Sophia Stock is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Sophia Stock has authored 16 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Sophia Stock's work include CAR-T cell therapy research (15 papers), Virus-based gene therapy research (6 papers) and Nanowire Synthesis and Applications (6 papers). Sophia Stock is often cited by papers focused on CAR-T cell therapy research (15 papers), Virus-based gene therapy research (6 papers) and Nanowire Synthesis and Applications (6 papers). Sophia Stock collaborates with scholars based in Germany, Japan and United States. Sophia Stock's co-authors include Leopold Sellner, Michael Schmitt, Maria‐Luisa Schubert, Carsten Müller‐Tidow, Anita Schmitt, Lei Wang, Ulrike Gern, Peter Dreger, Jean‐Marc Hoffmann and Brigitte Neuber and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Sophia Stock

13 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sophia Stock Germany	9	337	146	121	110	97	16	383
Martina Schüßler‐Lenz Germany	6	349 1.0×	180 1.2×	127 1.0×	103 0.9×	119 1.2×	9	445
Sharon Yim United States	5	348 1.0×	99 0.7×	103 0.9×	120 1.1×	93 1.0×	7	396
Yvette Bernal United States	11	375 1.1×	142 1.0×	135 1.1×	67 0.6×	117 1.2×	22	459
Joseph S. Durgin United States	9	271 0.8×	119 0.8×	106 0.9×	111 1.0×	75 0.8×	20	417
Elizabeth Halton United States	14	555 1.6×	117 0.8×	129 1.1×	141 1.3×	187 1.9×	29	604
Trisha R. Berger United States	9	373 1.1×	147 1.0×	175 1.4×	133 1.2×	102 1.1×	20	469
Katrin Mestermann Germany	4	430 1.3×	161 1.1×	149 1.2×	178 1.6×	139 1.4×	11	493
Claudia Diamonte United States	10	322 1.0×	73 0.5×	79 0.7×	84 0.8×	108 1.1×	18	353
Danielle Vanasse United States	6	507 1.5×	189 1.3×	135 1.1×	158 1.4×	142 1.5×	7	549
Jiazhen Cui China	11	312 0.9×	139 1.0×	118 1.0×	79 0.7×	76 0.8×	39	423

Countries citing papers authored by Sophia Stock

Since Specialization

Citations

This map shows the geographic impact of Sophia Stock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophia Stock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophia Stock more than expected).

Fields of papers citing papers by Sophia Stock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophia Stock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophia Stock. The network helps show where Sophia Stock may publish in the future.

Co-authorship network of co-authors of Sophia Stock

This figure shows the co-authorship network connecting the top 25 collaborators of Sophia Stock. A scholar is included among the top collaborators of Sophia Stock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophia Stock. Sophia Stock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Stock, Sophia, Veit Bücklein, Viktoria Blumenberg, et al.. (2025). Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma. HemaSphere. 9(1). e70062–e70062. 6 indexed citations

Stock, Sophia, Adrian Gottschlich, Janina Dörr, et al.. (2024). Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma. Cancer Immunology Immunotherapy. 73(6). 100–100. 2 indexed citations

Stock, Sophia, et al.. (2024). Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research. Methods in cell biology. 191. 329–352.

Stock, Sophia, et al.. (2023). Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control. International Journal of Cancer. 153(10). 1706–1725. 16 indexed citations

Stock, Sophia, et al.. (2023). CAR-T-Zellen zur Behandlung solider Tumoren. 13(3). 145–159. 1 indexed citations

Stock, Sophia, Adrian Gottschlich, Lisa Rohrbacher, et al.. (2023). Adaptor Anti-P329G CAR T Cells for Modular Targeting of AML. Blood. 142(Supplement 1). 4805–4805.

Stock, Sophia, Mohamed-Reda Benmebarek, Christian Jöst, et al.. (2022). Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors. Journal for ImmunoTherapy of Cancer. 10(7). e005054–e005054. 19 indexed citations

Stock, Sophia, et al.. (2022). Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners. Biomedicines. 10(2). 307–307. 15 indexed citations

Gong, Wenjie, Lei Wang, Sophia Stock, et al.. (2021). Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells. Cells. 10(1). 152–152. 4 indexed citations

10.

Stock, Sophia, Julian Marcon, Michael Chaloupka, et al.. (2021). Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor. Case Reports in Oncology. 14(1). 681–689.

11.

Wang, Sanmei, Leopold Sellner, Lei Wang, et al.. (2021). Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies. Oncology Reports. 46(2). 17 indexed citations

12.

Yoo, Keun-Young, Sophia Stock, Lei Wang, et al.. (2020). Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients. International Journal of Cancer. 148(2). 419–428. 52 indexed citations

13.

Stock, Sophia, Michael Schmitt, & Leopold Sellner. (2019). Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy. International Journal of Molecular Sciences. 20(24). 6223–6223. 106 indexed citations

14.

Gong, Wenjie, Jean‐Marc Hoffmann, Sophia Stock, et al.. (2019). Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells. Cancer Immunology Immunotherapy. 68(7). 1195–1209. 41 indexed citations

15.

Stock, Sophia, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, et al.. (2018). Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells. Human Gene Therapy. 29(10). 1167–1182. 21 indexed citations

16.

Hoffmann, Jean‐Marc, Maria‐Luisa Schubert, Lei Wang, et al.. (2018). Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients. Frontiers in Immunology. 8. 1956–1956. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact